Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Buscopan IBS Relief Drug Insights Forecast and Comparative Analysis 2016

Thursday, November 17, 2016 7:31
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher Drug Report, “Buscopan IBS Relief- Drug Insights, 2016″ highlights the Buscopan IBS Relief marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher’s report covers the Global Market Assessment of the Buscopan IBS Relief covering the total sales estimation and also provides the Buscopan IBS Relief sales performance during the historical period and forecast period to 2018. Publisher’s Report also covers the detailed clinical assessment of Buscopan IBS Relief, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, Publisher’s Report provides the SWOT analysis for the Buscopan IBS Relief.
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

 

For more information about this report: http://www.reportsweb.com/buscopan-ibs-relief-drug-insights-2016

Report Scope

 

-A review of the Buscopan IBS Relief based on information derived from company and industry-specific sources

-Coverage of the Marketed data of the Buscopan IBS Relief on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification

-Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Buscopan IBS Relief with location details

-Patent Expiry Timeline and Exclusivity Details

-Route of Synthesis of the API

-Global Forecasted Sales Figure to 2018

-Qualitative and quantitative assessment of market space

-SWOT Analysis

 

Reasons to buy

 

-Evaluate the marketing status and exclusivity details of Buscopan IBS Relief to exploit opportunities for generic drug development opportunities.

-Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Buscopan IBS Relief.

-API intelligence over Buscopan IBS Relief and gaining primary intelligence over Active Ingredients manufacturers across the globe.

-Understanding the chemical route of synthesis of Buscopan IBS Relief.

-Uncovering opportunities in the rapidly growing the US market

-Stay ahead of competition by understanding the changing competitive landscape

-Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

-Make more informed business decisions from insightful and in-depth analysis of the drug’s performance

-Obtain sales forecast for currently marketed drug for to 2018

 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW000182641/sample

 

Table of Contents

1. DelveInsight Report Introduction 
2. Buscopan IBS Relief Overview
2.1 Market Competition
2.3 Competitors in Development
3 Global Sales Assessment
3.1 Historical Sales of Buscopan IBS Relief
3.2 Forecasted Sales of Buscopan IBS Relief
4 Product Description
4.1 Mechanism of Action
4.2 Pharmacodynamic Properties 
4.3 Pharmacokinetic Properties
5 Marketed Details 
5.1 United States 
5.2 Europe
6 Patent Information 
6.1 Patent Numbers and Expiry Details
6.2 Patent and Exclusivity Expiry Assessment United States (US)
6.3 Patent Details
7 Route of Synthesis
8 Global API Manufacturers Assessment
8.1 The United States Drug Master File (US DMF)
8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India
9 Generic Players
10 The Pipeline Coverage
11 Clinical Trials Information
11.1 Clinical Trials by Zone
12 Company Profile
12.1 Company Summary
12.2 Company Financials
13 SWOT Analysis

 

Inquire before Buying at http://www.reportsweb.com/inquiry&RW000182641/buying

 

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.